Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients
dc.contributor.author | Yuce-Artun, Nazan | |
dc.contributor.author | Baskak, Bora | |
dc.contributor.author | Ozel-Kizil, Erguvan Tugba | |
dc.contributor.author | Ozdemir, Hatice | |
dc.contributor.author | Uckun, Zuhal | |
dc.contributor.author | Devrimci-Ozguven, Halise | |
dc.contributor.author | Suzen, Halit Sinan | |
dc.date.accessioned | 2020-06-25T18:16:41Z | |
dc.date.available | 2020-06-25T18:16:41Z | |
dc.date.issued | 2016 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description | ozguven, halise/0000-0002-9355-2757; Suzen, Sinan/0000-0003-1779-5850; OZEL-KIZIL, ERGUVAN TUGBA/0000-0001-9657-1382 | |
dc.description.abstract | Background Genetic polymorphisms in CYP2B6 and CYP2C19 may cause variability in the metabolism of sertraline, a widely used antidepressant in major depressive disorder treatment. Objective This study investigates the impact of CYP2B6*4 (785A > G), CYP2B6*9 (516G > T), CYP2B6*6 (516G > T + 685G > A) CYP2C19*2 (685G > A), CYP2C19*17 (-3402C > T) polymorphisms on plasma concentrations of sertraline and N-desmethyl sertraline in major depression patients treated with sertraline [n = 50]. Setting Participants were patients who admitted to an adult psychiatry outpatient unit at a university hospital. These were DSM-IV major depression diagnosed patients with a stable sertraline medication regimen [for at least one month]. Methods CYP2B6*4 (rs 2279343; 785A > G), CYP2B6*9 (516G > T; rs 3745274), CYP2B6*6 (516G > T + 685G > A) CYP2C19*2 (rs 4244285; 685G > A), CYP2C19*17 (rs 11188072; -3402C > T), polymorphisms were analyzed by polymerase chain reaction and restriction fragment length polymorphism. Plasma concentrations were measured by high-performance liquid chromatography in patients treated with SERT. Main outcome measure The distribution of CYP2B6*4, *6, *9 and CYP2C19*2, *17 among patient group and the association between genotype and sertraline metabolism. Results Sertraline, N-desmethyl sertraline, N-desmethyl sertraline/sertraline and dose-adjusted plasma concentrations were statistically compared between individuals with wild-type and variant alleles both for CYP2B6 and CYP2C19 enzymes. The mean N-desmethyl sertraline/sertraline value, was significantly lower in all subgroups with *6 and *9 variant alleles (p < 0.05). Sertraline/C values were significantly higher (p < 0.05) and N-desmethyl sertraline/C values were lower in all subgroups with *6 and *9 variant alleles compared to wild-type subgroup. Conclusion CYP2B6*6 and *9 variant alleles had a significant decreasing effect on sertraline metabolism in major depression patients which might result as variations in sertraline therapy. | en_US |
dc.identifier.citation | closedAccess | en_US |
dc.identifier.doi | 10.1007/s11096-016-0259-8 | |
dc.identifier.endpage | 394 | en_US |
dc.identifier.issn | 2210-7703 | |
dc.identifier.issn | 2210-7711 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 26830411 | |
dc.identifier.scopus | 2-s2.0-84962958394 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 388 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s11096-016-0259-8 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/6596 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.wos | WOS:000374326900029 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Springer | en_US |
dc.relation.ispartof | International Journal Of Clinical Pharmacy | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | CYP2B6 | en_US |
dc.subject | CYP2C19 | en_US |
dc.subject | Cytochrome P450 | en_US |
dc.subject | Sertraline | en_US |
dc.subject | Pharmacogenetics | en_US |
dc.title | Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients | en_US |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
[ X ]
- İsim:
- Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients.pdf
- Boyut:
- 455.96 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text